Dyne Therapeutics Inc (DYN)
29.73
-0.26
(-0.87%)
USD |
NASDAQ |
Nov 21, 16:00
29.36
-0.37
(-1.24%)
Pre-Market: 08:29
Dyne Therapeutics Total Liabilities (Quarterly): 63.30M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 63.30M |
| June 30, 2024 | 50.69M |
| March 31, 2024 | 44.22M |
| December 31, 2023 | 73.79M |
| September 30, 2023 | 53.21M |
| June 30, 2023 | 44.54M |
| March 31, 2023 | 46.71M |
| December 31, 2022 | 53.96M |
| September 30, 2022 | 49.94M |
| June 30, 2022 | 52.97M |
| Date | Value |
|---|---|
| March 31, 2022 | 51.30M |
| December 31, 2021 | 57.47M |
| September 30, 2021 | 52.76M |
| June 30, 2021 | 14.55M |
| March 31, 2021 | 13.45M |
| December 31, 2020 | 10.97M |
| September 30, 2020 | 14.63M |
| June 30, 2020 | 14.29M |
| December 31, 2019 | 2.40M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.40M
Minimum
Dec 2019
73.79M
Maximum
Dec 2023
40.27M
Average
49.94M
Median
Sep 2022
Total Liabilities (Quarterly) Benchmarks
| Sarepta Therapeutics Inc | 2.379B |
| Capricor Therapeutics Inc | 24.69M |
| Regenxbio Inc | 217.70M |
| Catalyst Pharmaceuticals Inc | 111.07M |
| Novavax Inc | 2.239B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 768.84M |
| Shareholders Equity (Quarterly) | 705.54M |